期刊文献+

高致病性禽流感H5N1病毒M1蛋白的重组表达及在感染检测中的初步应用 被引量:1

Expression of recombinant matrix protein 1 from H5N1 influenza virus and its application in diagnosis of infection
原文传递
导出
摘要 目的:原核表达重组高致病性禽流感基质蛋白M1并分析其在感染检测中的作用。方法:根据NCBI公布的基质蛋白M1的核苷酸序列设计特异性引物,用高致病禽流感H5N1病人分离的病毒提取病毒RNA进行反转录合成cD-NA,扩增基质蛋白M1基因。将M1基因克隆到pQE30原核表达载体进行非融合表达,纯化重组表达的蛋白并用免疫学方法检测分析。结果:克隆了高致病禽流感H5N1病毒基质蛋白M1基因,并采用pQE30原核表达载体成功表达该蛋白。以该重组蛋白为检测包被抗原建立间接ELISA,检测6份病人血清标本均为阳性,而正常对照人群为阴性。结论:高致病禽流感H5N1病毒M1蛋白可以应用于感染检测中。 Objective: To express M 1 of H5N1 influenza virus and analyze its function in in diagnosis of infection.Methods: The cDNA of an H5N1 influenza virus(2006/Shenzhen) and specific primers were used to amplify the M1 gene.After sequencing,M1 gene was subcloned into vector pQE30 to express M1 protein.Further, Purified M1 protein was analyzed by immunological method.Results: The pQE30-M1 expression vector was successfully constructed.Recombinant M1 protein was purified with Ni-NTA affinity chromatography and further used as detection antigen for indirect ELISA.All the 6 sera samples from patients were positive while samples from healthy donor were negative.Conclusion: The recombinant M1 protein can be applied in diagnosis of H5N1 infection.
出处 《中国卫生检验杂志》 CAS 2011年第9期2117-2119,共3页 Chinese Journal of Health Laboratory Technology
基金 十一五传染病重大专项动物模型课题(2009ZX1004-401)
关键词 高致病禽流感2006年深圳株H5N1病毒 基质蛋白M1 非融合表达 Highly pathogenic H5N1 virus Matrix protein 1 Unfused expression
  • 相关文献

参考文献8

  • 1Carrat F, Flahault A. Influenza vaccine:The challenge of antigenic drift [ J ]. Vaccine,2007,25 ( 39 - 40) :6852 - 6862.
  • 2Roti M, Yang J, Berger D, Huston L, et al. Healthy Human Subjects Have CD4 + T Ceils Directed against H5N1 Influenza Virus [ J]. J Immunol,2008,180 : 1758 - 1768.
  • 3Wat anabe K, Handa H, Mizumoto K, et al. Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein [ J ] . J Virol, 1996,70 : 241 - 247.
  • 4Hankins RW, Nagata K, Kato A, et al. Mechanism of influenza virus transcription 46 inhibition by matrix ( M1 ) protein [ J ]. Res Virol, 1990,141:305 - 314.
  • 5Doherty PC, Turner SJ, Webby RG, et al. Influenza and the challenge for immunology [ J ]. Nat Immunol, 2006,7:449 - 455.
  • 6Epstein SL, Lo CY, Misplon JA, et al. Mechanism of protective immunity against influenza virus infection in mice without antibodies [ J ]. J Immunol,1998,160( 1 ) :322 - 327.
  • 7Jimenez GS, Planchon R, Wei Q, et al. Vaxfectin -formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge [J]. Hum Vaccin, 2007, 3(5) : 157 - 164.
  • 8Geurtsvan Kessel CH, Willart MA, van Rijt LS, et al. Clearance of influenza virus from the lung depends on migratory langerin + CD11b - but not plasmacytoid dendritic cells [ J ]. J Exp Med, 2008,205 ( 7 ) : 1621 - 1634.

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部